Introduction
Potential therapies for airway disease that employ genetransfer techniques or application of pharmaceutical agents require a simple and relevant animal model for testing. Widespread interest in gene therapy for cystic fibrosis (CF) airway disease has led to the development of mouse models. Aspects of the nasal cavity of mice have proved to be a good model of human lower airway ciliated epithelium. Along with simple access, mouse nasal airways (rather than pulmonary airways) exhibit in some regions a respiratory epithelium with cell composition and ion transport properties similar to human lower airways. 1 The well-differentiated ciliated cells that are a primary target tissue in therapy for CF airway disease 2 are selectively found in respiratory (RE) and transitional (TE) epithelium that line the mouse nasal cavity. However, RE and TE exist in a complex axial and lateral relationship with the olfactory (OE) and squamous (SE) epithelia that line at least 50% of the surface of the mouse nasal cavity. 3 Recent studies have raised the possibility that the less relevant OE is transduced at least as efficiently as RE. 4 Correspondence: DW we found TPD values did not discriminate between respiratory and olfactory epithelia. We next assessed relationships between anatomic regions accessed by the TPD cannula and epithelial type. The frequently used insertion depth of approximately 5 mm from the nose tip predominantly recorded the TPD from anterior dorsal olfactory epithelium. Measurement of the TPD of respiratory epithelium in our study was maximized by insertion of the TPD cannula probe to 2.5 mm depth. Because TPD measurements are not sensitive to epithelial type, adequate control of position and TPD catheter insertion depth are required to ensure accurate estimation of CFTR gene transfer into the target RE in the mouse nasal cavity. Gene Therapy (2000) 7, 1810-1815.
In a study examining enhancement of adenoviral gene transfer, 5 we noted that the adenovirus vector (AdV) efficiently transduced the lacZ gene into the olfactory epithelium (OE) of the mouse nose and we excluded transduced OE from our measures of gene transfer success. These findings suggested that transduction of OE probably also occurred with AdV transduction of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Accordingly, functional estimates of the presence and/or the magnitude of CFTR gene transfer in our study and in other studies may have been confounded by transduction of, and TPD measurement from nontarget OE.
The nasal transepithelial potential difference (TPD) is used in mice to measure CFTR gene transfer, but these TPD studies are performed 'blind', ie the fine recording cannula is simply inserted a specified depth into a nostril. Neither the anatomical study of Mery et al 3 nor other literature allow prediction of which major nasal meatus a TPD nasal cannula would enter, nor the type of epithelium contacted. Importantly, the bioelectric correlates of RE versus OE physiological function have not been reported.
In preliminary investigations, we found that a TPD cannula could potentially reach any of the four types of epithelium lining the mouse nasal cavity. The age (size) of the animal, its orientation during cannula insertion, and the orientation of the cannula itself during and after insertion could influence the eventual location of the cannula tip in the mouse nose. Therefore, in this study, we systematically examined the relationships between TPD insertion depth, the type of airway epithelium probed by the TPD cannula, and the measured TPD values. We describe new electrodeposition marking methodology utilizing routine electrophysiological and histochemical techniques to identify the type of epithelium that generates the TPD signals.
Results
Effects of TPD cannula insertion into mouse nasal airway The electrodeposition TPD cannula ( Figure 1 ) was inserted 2.5 mm, 5.0 mm or 7.5 mm into the nose in anaesthetised animals to measure TPD and to mark the location of the cannula tip. We noted that apart from markings of the cannula-tip location yielded by electrodeposition (Figure 2a) , the cannula itself often produced focal epithelial damage. Typically, disruption or removal of columnar epithelial cells was present in Gene Therapy locations adjacent to ( Figure 2b ) and more rostral to (Figure 2c ) regions where the TPD or electrodeposition procedures were performed. We used these regions of damage and the presence of Prussian Blue (PB) electrodeposition stains (see Materials and methods) to establish the cell type in the vicinity of the TPD cannula tip.
We recorded the position of all marks in the anterior airway regions due to cannula abrasion and/or PB markings to determine: (1) where the TPD cannula entered the nostril; (2) the route it took within the nasal airways; and (3) in which region the cannula tip rested after insertion. At the 2.5 mm depth, the TPD cannula had entered, traversed, or lay in the dorsal, dorso-medial, or medial meatus in 15 of 16 nostrils (see Figure 2 for meatal terminology). In the remaining case, PB staining in the lateral meatus was observed.
Epithelium type and depth of TPD cannula insertion
We studied animals that were either suspended by their incisors or laid supine. We first examined the specific type of epithelium marked immediately adjacent to the TPD cannula tip when it was placed 2.5 mm, 5.0 mm and 7.5 mm into the nose of mice suspended by their incisors. At 2.5 mm depth, ciliated respiratory epithelium was present in all but one case, in which marks identified RE and adjacent squamous epithelium (SE) simultaneously. In contrast, at the commonly used TPD measurement depth of 5.0 mm (see Discussion) RE was typically not present, whereas OE was frequently found (Table 1) . Only olfactory epithelium was encountered at 7.5 mm (n = 4), suggesting that a purely olfactory region of the nose had been reached.
In the supine mouse studies RE was present in all four cases at 2.5 mm depth, while at 5.0 mm depth there was no predominant cell type ( Table 1) .
Relationships of basal TPD and ⌬PD as a function of cannula depth/epithelium type We next examined the basal TPD and the ⌬PD values that were recorded for specific epithelial types as defined by electrodeposition marks. In OE at 7.5 mm (suspended mice), the mean basal TPD and the ⌬PD measured just before PB marking was −0.3 ± 2.1 mV and −12.2 ± 1.2 mV, respectively (n = 4). When the TPD at other measurement Table 1 ). Similarly, no differences were noted between 2.5 and 7.5 mm depth in the suspended protocol.
Depth-related differences in TPD and epithelium type in CF mice
There is no information available on whether the CFTR genotype results in an altered distribution of nasal airway epithelium in CF mice. Because CF mice were not available to study TPD location directly, we examined nasal airway epithelium in the dorsal meatus of 36 CF colony mice, using archived nasal airway sections from approximately 5 mm depth prepared in earlier studies ) from an Australian colony that were to be culled to prevent spread of an MHV infection.
The distributions of nasal epithelial type in CF mice (in archival CF colony nasal sections) mimicked those observed in non-CF mice from that colony. At 5.0 mm, RE was present in only six of 36 animals. The epithelial type most often found in the dorsal meatus at this depth was olfactory (30 of 36 animals, P = 0.005). There was no significant difference in genotype proportions (CF versus non-CF) for mice possessing OE or RE at this level (P = 0.97 and P = 0.89, respectively). In the three CF mouse heads sectioned specifically for these studies, we found similar distributions of nasal epithelium at 2.5 mm and 5 mm to those observed in normal colony mice.
Discussion
Studies measuring TPD in mouse nasal airways have not considered the diversity of the epithelial types present at different levels of the nasal cavity. Recently, the distribution of the different epithelial types in the mouse nasal cavity was documented. 3 Starting at the nasal opening, squamous epithelium (SE) lines the cartilaginous softtissue of the nose tip. Proceeding caudally along the dorsal meatus (ie mimicking the usual path of a TPD cannula insertion -see above), a ciliated respiratory epithelium (RE) is reached which extends ventrally down the septum to meet a small SE region on the floor of the nasal cavity. As deeper levels are reached, olfactory epithelium (OE) expands to occupy the dorsal meatus and most of the remaining nasal cavity, except for the RE present around the floor of the nose and the thin tracks of RE along the tips of olfactory turbinates and scrolls.
Our findings show that the TPD cannula usually enters the nasal airways via the dorsal, the dorso-medial, or the medial meatus, suggesting that placement of the TPD cannula at 2.5 mm, rather than 5.0 or 7.5 mm, should provide TPD measurements derived from ciliated RE in the dorsal or middle meatus. Rarely, squamous epithelium in the nose tip may contribute to TPD measurements at 2.5 mm because of its proximity at this level. 3 Squamous epithelium was present at 2.5 mm once in the suspended mouse series, whereas only RE was found at 2.5 mm in our small series of supine mice (Table 1) .
In contrast, the epithelial type at 5.0 mm from the nose tip (Table 1 ) was variable. With both the suspended and supine approaches at 5.0 mm depth, the epithelium could be of the OE or RE type. The specific depth at which the change between RE and OE occurs will alter with age (which will affect nasal cavity size) and with individual variability.
Although abrasion of nasal epithelium is known to lower TPD, 6 the damage to epithelium caused by a TPD cannula (Figure 1 and 2c) does not appear to have been previously described. With hindsight, damage should be expected when a rigid cannula traverses or rests against fragile airway epithelium. The localized damage observed (Figure 2b, c) did not obliterate TPD values, and similar damage could be expected to occur to varying degrees in the TPD studies of other groups, depending on the type of cannula used. We speculate that TPD magnitude in vivo could be consistently altered by abrasion damage under all ionic and pharmacological environments employed due to partial shunting of the regional electrical potential through the damaged areas. Since adenoviral gene transfer is strong in damaged/repairing epithelium, 7 cannula damage could also influence the level of gene transfer if experimental protocols require vector to be introduced after TPD measurement, but before full repair of the damaged areas.
Despite major differences in the cell types that comprise RE and OE, the basal TPDs and ⌬PDs were surprisingly similar. Although there is a paucity of reports characterizing the ion transport properties of mouse OE, similar bioelectrics have been reported in excised nasal RE and OE from CF mice. 1 In that study, both tissue types displayed the hyperabsorption of Na + and the defect in cAMP-mediated Cl − secretion typical of CF. Recent in situ hybridization studies have demonstrated relatively high levels of CFTR, ENaC and NKCC-1 cotransporter activity in both mouse RE and OE. 8 Based on previous studies, it is likely that the sustentacular cells in OE exhibit a transepithelial ion transport function to regulate the liquid in the environment of the olfactory neuronal cells, and our TPD data under basal and low chloride conditions suggests that the gross electrophysiological function of mouse olfactory epithelium can mimic the transepithelial electrophysiology of respiratory epithelium. Since the basal TPD and the TPD responses to low Cl − solutions cannot discriminate olfactory epithelium from respiratory epithelium, the relative contribution of each type of epithelium to a mouse nasal TPD measurement cannot be determined. It follows that the effects of pharmacological agents used in more detailed studies of ion control in respiratory epithelium (eg amiloride, isoproterenol, UTP, forskolin) should now be examined in nasal respiratory and olfactory epithelium during TPD measurement, since their use may assist in discriminating between OE and RE. However, until such data are available, the only way to ensure that the TPD is measuring RE function is by physical knowledge of catheter placement.
A variety of TPD measurement depths have been used previously. In CF mouse and gene-transfer studies where a single measurement depth was used, the TPD cannula tip was usually placed 5.0 mm from the nostril opening, [8] [9] [10] [11] or between 4 mm and 5 mm. [12] [13] [14] Measurement depth has also been set by advancing the cannula until a maximal basal TPD was obtained -at 4-6 mm, 15 at 3-5 mm, 16 and at an undefined depth. 17 In one study the TPD tip was placed 8-12 mm deep. 18 If the distribution of nasal epithelium in these various CF mice and gene-transfer studies parallels that in our cftr tm1unc and non-CF mice, some of the reported TPDs and pharmacological responses in these studies may have derived from olfactory rather than respiratory epithelium.
In pilot studies we were unable to place a TPD cannula in the large anterior lateral meatus by changing the cannula entry point or its insertion angle at the nares, supporting our finding that a TPD cannula enters, and remains in or near the dorsal meatus. Body orientation appears not to be the key to the measurement of TPD selectively for RE. Measurement of RE is ensured at 2.5 mm depth with both orientations and measurement at 5 mm is too variable to suggest one orientation as preferable. Technically, we prefer the suspended position because it provides optimal visualization of the nares for Gene Therapy cannula insertion, minimizes breathing problems due to the cannula perfusion (wicking of excess perfusion fluid is not required), and the cannula and reference electrode are easily placed.
Although our studies of CF mouse nasal airways were limited, the results suggest that the distributions of nasal airway epithelium in these mice are similar to those in normal colony mice. Despite CF mice being underweight (ie undersize) compared with their non-CF littermates, 1 we found that RE was also present at 2.5 mm depth in the dorsal meatus, and that OE was present at 5.0 mm depth. These findings suggest that the relationships we describe between epithelial type, TPD cannula placement depth, and TPD values in non-transgenic mice warrant similar careful consideration when CF mouse (cftr tm1unc ) nasal airways are examined using TPD techniques.
In summary, the anatomical and morphological complexity of the epithelium lining mouse nasal airways suggests care should be exercised if they are to be accurate in vivo models of respiratory airway physiology and function. The nasal airways of transgenic CF mice provide the only non-human respiratory tissue that is anatomically and physiologically appropriate for studies of the success of pre-clinical developments in CF airway gene transfer. It is therefore important that gene transfer into respiratory epithelium (only) is accurately measured. Since OE can be transduced with Ad vectors as easily as RE, and since RE and OE are functionally similar as measured by transepithelial potential difference measures, the only direct assessment of the epithelial type generating the TPD under the TPD sensing cannula is correct anatomic catheter placement. When TPD studies are performed in 6-to 12-week-old mice using the protocols described here, cannula placement 2.5 mm from the nose tip should maximize the ability to record from nasal airway respiratory epithelium.
Materials and methods

Animals
Normal female 6-to 12-week-old C57Bl/6 mice were housed in small social groups within filter-top cages bedded with paper pellets. Animal studies operated under the approval of the Animal Ethics Committee, Women's and Children's Hospital, Adelaide, South Australia. Mice were anaesthetised with a xylazine (20 mg/ml):ketamine (100 mg/ml) mixture (30 l of a 3:2 mixture, per 20 g body weight, i.m.). Studies with transgenic CF mice (cftr tm1unc ) utilized archival sections and sections cut from freshly prepared CF mouse noses.
Nasal transepithelial potential difference (TPD) -general procedures and modifications
Either nostril was used for TPD assessments. In our routine studies for TPD measurement and for cannula position marking, anaesthetised mice were oriented vertically via a wire loop that ensnared their dorsal incisors, while supported on their hindquarters. For comparison purposes, we included a small group of mice that were examined in a supine orientation. A single investigator (PJH) performed all the TPD studies. The slight natural curve often present in the TPD cannula was arranged so that the orientation of the curve allowed smooth insertion into the nostril.
We modified the normal polyethylene TPD cannula (PE10, Intramedic, Becton Dickinson, NJ, USA; heatdrawn) to allow electrolytic marking of the location of the cannula tip in the nasal airway once TPD measurements had been completed. A 25 m diameter insulated stainless-steel wire (CFW 19225 -TMLSR-1; California Fine Wire, Grover Beach, CA, USA) was bared approximately 1.5 cm at the tip and threaded towards the distal end of the polyethylene TPD cannula to provide marking capability (Figure 1 ). Suction applied to the cannula tip assisted in drawing the wire through the fine cannula tubing. The proximal end of the wire exited the cannula at a convenient junction with larger diameter silicon tubing of the perfusion system, and the wire was attached to a current source (A360 Stimulus Isolator, WPI, Sarasoto, FL, USA). This connection was independent of the input TPD circuit, and permitted positive current (10-50 A, 2-5 min) to be passed through the wire once TPD measures were completed.
Application of positive current to the wire oxidizes elemental iron to Fe 2+ and Fe 3+ ions that are deposited on adjacent tissue. Fe ions were visualized using a modified Prussian Blue reaction, based on the procedures used to mark steel electrode tracks and positions in brain stimulation studies. 19 After asphyxiation in 100% CO 2 , the heart was bled, head removed, and the nasal passages flushed gently via the exposed trachea with the Prussian Blue fixative. This solution comprised 3% potassium ferricyanide, 3% potassium ferrocyanide, and 0.5% trichloroacetic acid (Sigma Chemical) in 10% neutral buffered formalin. The heads remained immersed (protected from light) in this solution overnight, then were rinsed in distilled water and decalcified for 22 h (7% HCl in 2% EDTA). When dehydration processing reached 70% ethanol, the head was grossly sectioned into tissue segments for wax embedding. The cut surfaces and the nasal airways were then examined and photographed via a stereomicroscope before embedding. Prussian Blue-stained regions of epithelium were noted, and cross-sections were counter-stained with hematoxylin/eosin or neutral red.
Basal TPD and ⌬PD measurement The TPD cannula was attached to the perfusion/ recording apparatus comprised of a modified dual syringe pump (IVAC 770, San Diego, CA, USA) and a WPI Isomillivoltmeter. The cannula was marked with a fine permanent marker (Nalgene Cryoware Marker, Nalge Nunc International, NY, USA) at positions 2.5 mm, 5.0 mm and 7.5 mm from the cannula tip. These marks ensured accurate placement of the cannula tip at designated depths. A baseline TPD was recorded during perfusion of Krebs Ringer (KBR) from the tip at 0.3 l/min. The perfusate was then switched to a low-chloride solution (NaCl replaced with Na gluconate; Cl − concentration of approximately 5.0 mm compared with approximately 120 mm in KBR), 12 and the new TPD recorded. The magnitude of the difference between basal TPD and the low-chloride TPD was denoted as the ⌬PD. TPD values were measured from continuous chart paper recordings once the signal had plateaued for a period of 1-2 min; signals reached a plateau 5-10 min after cannula insertion or after a change of perfusion fluid. Data were not corrected for liquid junction potentials.
Cannula location and epithelium type
Single or multiple measurements were taken from individual animals. In tissue blocks and cross-sections we counted all sites of PB-stained epithelium or of localized cannula-induced damage to epithelium. 'En-route' cannula-induced damage (eg where focal epithelium damage was present at 2.5 mm, in the context of a protocol designating insertion to 5.0 mm) was also included. Most cases provided unequivocal identification of a single type of epithelium, but in three cases marks encompassed the boundary of two adjacent epithelia.
Statistics TPD values were normally distributed and were compared using t tests; proportions were compared using the z test (Sigmastat 2.0; Jandel Corp, San Rafael, CA, USA). Statistical significance was set at P = 0.05.
